Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue JAN, 2013, Pages

  Ktsoyan, Zhanna A ^a   Beloborodova, Natalia V ^b   Sedrakyan, Anahit M ^a   Osipov, George A ^b   Khachatryan, Zaruhi A ^a   Manukyan, Gayane P ^a   Arakelova, Karine A ^a   Hovhannisyan, Alvard I ^a   Arakelyan, Arsen A ^a   Ghazaryan, Karine A ^a   Zakaryan, Magdalina K ^a   Aminov, Rustam I ^c  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Colchicine; Discriminant function analysis; Familial mediterranean fever; Gas chromatography mass spectrometry (GC MS); Metabolome; Microbial long chain fatty acids

Indexed keywords

10 HYDROXY STEARIC ACID; 2 HYDROXY LAURIC ACID; 3 HYDROXY STEARIC ACID; 3 HYDROXYDODECANOIC ACID; ANTE ISO HEPTADECANOIC ACID; ANTEISO HEPTADECANOIC ACID; ANTEISO NONADECANOIC ACID; ANTEISO PENTADECANOIC ACID; CIS 11 EICOSENOIC ACID; CIS 11 HEXADECENOIC ACID; CIS 11 TETRADECENOIC ACID; CIS 7 HEXADECENOIC ACID; CIS 9 EICOSENOIC ACID; CIS 9 HEPTADECENOIC ACID; CIS 9 PENTADECENOIC ACID; CIS 9 TETRADECENOIC ACID; CIS VACCINIC ACID; COLCHICINE; CYCLOPROPYL HEPTADECANOIC ACID; CYCLOPROPYL NONADECANOIC ACID; ISO HEPTADECANOIC ACID; ISO MYRISTIC ACID; ISO PALMITIC ACID; ISO PENTADECANOIC ACID; ISO STEARIC ACID; LONG CHAIN FATTY ACID; MYRISTIC ACID; OLEIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCENIC ACID; FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; ION MONITORING; MALE; MASS FRAGMENTOGRAPHY; METABOLOME; MIDDLE AGED; YOUNG ADULT; COHORT ANALYSIS; DISCRIMINANT FUNCTION ANALYSIS; DRUG EFFECT; GAS CHROMATOGRAPHY/MASS SPECTROMETRY (GC/MS); METABOLISM; MICROBIAL LONG CHAIN FATTY ACIDS;

COLCHICINE; DISCRIMINANT FUNCTION ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; GAS CHROMATOGRAPHY/MASS SPECTROMETRY (GC/MS); METABOLOME; MICROBIAL LONG CHAIN FATTY ACIDS;

ADOLESCENT; ADULT; COHORT STUDIES; COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; FATTY ACIDS; FEMALE; HUMANS; MALE; METABOLOME; MIDDLE AGED; YOUNG ADULT;

EID: 84897921672     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2013.00002     Document Type: Article

References (36)

1. Aksentijevich, I., Torosyan, Y., Samuels, J., Centola, M., Pras, E., Chae, J. J., et al. (1999). Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am. J. Hum. Genet. 64, 949-962.
2. Artis, D. (2008). Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8, 411-420.
3. Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., and Gordon, J. I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920.
4. Barakat, M. H., Gumaa, K. A., El-Khawad, A. O., El-Sobki, N., and Fenech, F. F. (1984). Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever. Lancet 323, 656-657.
5. Beloborodova, N. V., and Osipov, G. A. (2000). Small molecules originating from microbes (SMOM) and their role in microbes-host relationship. Microb. Ecol. Health Dis. 12, 12-21.
6. Ben-Chetrit, E., Bergmann, S., and Sood, R. (2006). Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology 45, 274-282.
7. Corona, E., Dudley, J. T., and Butte, A. J. (2010). Extreme evolutionary disparities seen in positive selection across seven complex diseases. PLoS ONE 5:e12236. doi: 10.1371/journal.pone.0012236
8. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785.
9. Jalkh, N., Génin, E., Chouery, E., Delague, V., Medlej-Hashim, M., Idrac, C. A., et al. (2008). Familial Mediterranean fever In Lebanon: founder effects for different MEFV mutations. Ann. Hum. Genet. 72, 41-47.
10. Kallinich, T., Haffner, D., Niehues, T., Huss, K., Lainka, E., Neudorf, U., et al. (2007). Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 119, e474-e483.
11. Khachatryan, Z. A., Ktsoyan, Z. A., Manukyan, G. P., Kelly, D., Ghazaryan, K. A., and Aminov, R. I. (2008). Predominant role of host genetics in controlling the composition of gut microbiota. PLoS ONE 3:e3064. doi: 10.1371/journal.pone.0003064
12. Ktsoyan, Z. A., Beloborodova, N. V., Sedrakyan, A. M., Osipov, G. A., Khachatryan, Z. A., Kelly, D., et al. (2010). Profiles of microbial fatty acids in the human metabolome are disease-specific. Front. Microbiol. 1:148. doi: 10.3389/fmicb.2010.00148
13. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
14. Livneh, A., Langevitz, P., Zemer, D., Zaks, N., Kees, S., Lidar, T., et al. (1997). Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40, 1879-1885.
15. Macpherson, A. J., and Harris, N. L. (2004). Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478-485.
16. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
17. Manukyan, G. P., Ghazaryan, K. A., Ktsoyan, Z. A., Tatyan, M. V., Khachatryan, Z. A., Hakobyan, G. S., et al. (2008a). Cytokine profile of Armenian patients with familial Mediterranean fever. Clin. Biochem. 41, 920-922.
18. Manukyan, G. P., Ghazaryan, K. A., Ktsoyan, Z. A., Khachatryan, Z. A., Arakelova, K. A., Kelly, D., et al. (2008b). Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition. PLoS ONE 3:e3172. doi: 10.1371/journal.pone.0003172
19. Manukyan, G. P., Ghazaryan, K. A., Ktsoyan, Z. A., Khachatryan, Z. A., Kelly, D., Tatyan, M. V., et al. (2010). Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions. Cytokine 50, 146-151.
20. Massarotti, A., Coluccia, A., Silvestri, R., Sorba, G., and Brancale, A. (2012). The tubulin colchicine domain: a molecular modeling perspective. ChemMedChem 7, 33-42.
21. Mazmanian, S. K., Round, J. L., and Kasper, D. L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625.
22. Niel, E., and Scherrmann, J. M. (2006). Colchicine today. Joint Bone Spine 73, 672-678.
23. Osipov, G. A., Boiko, N. B., Fedosova, N. F., Kasikhina, S. A., and Lyadov, K. V. (2009). Comparative gas chromatography-mass spectrometry study of the composition of microbial chemical markers in faeces. Microb. Ecol. Health Dis. 21, 159-171.
24. Osipov, G. A., and Turova, E. S. (1997). Studying species composition of microbial communities with the use of gas chromatography-mass spectrometry. Microbial community of kaolin. FEMS Microbiol. Rev. 20, 437-446.
25. Ozçelik, B., Kartal, M., and Orhan, I. (2011). Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm. Biol. 49, 396-402.
26. Papadopoulos, V. P., Giaglis, S., Mitroulis, I., and Ritis, K. (2008). The population genetics of familial Mediterranean fever: a meta-analysis study. Ann. Hum. Genet. 72, 752-761.
27. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
28. Sartor, R. B. (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390-407.
29. Schaner, P., Richards, N., Wadhwa, A., Aksentijevich, I., Kastner, D., Tucker, P., et al. (2001). Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states. Nat. Genet. 27, 318-321.
30. Schwabe, A. D., and Peters, R. S. (1974). Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore) 53, 453-462.
31. Sohar, E., Gafni, J., Pras, M., and Heller, H. (1967). Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am. J. Med. 43, 227-253.
32. Spor, A., Koren, O., and Ley, R. (2011). Unraveling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279-290.
33. The French FMF Consortium. (1997). A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25-31.
34. The International FMF Consortium. (1997). Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797-807.
35. Van Limbergen, J., Russell, R. K., Nimmo, E. R., and Satsangi, J. (2007). The genetics of inflammatory bowel disease. Am. J. Gastroenterol. 102, 2820-2831.
36. Yenokyan, G., and Armenian, H. K. (2012). Triggers for attacks in familial Mediterranean fever: application of the case-crossover design. Am. J. Epidemiol. 175, 1054-1061.